<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id><journal-id journal-id-type="publisher-id">JVMS</journal-id><journal-title-group><journal-title>The Journal of Veterinary Medical Science</journal-title></journal-title-group><issn pub-type="ppub">0916-7250</issn><issn pub-type="epub">1347-7439</issn><publisher><publisher-name>The Japanese Society of Veterinary Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26902693</article-id><article-id pub-id-type="pmc">4905837</article-id><article-id pub-id-type="publisher-id">15-0572</article-id><article-id pub-id-type="doi">10.1292/jvms.15-0572</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject><subj-group><subject>Full Paper</subject></subj-group></subj-group></article-categories><title-group><article-title>Anti-NDV activity of baicalin from a traditional Chinese medicine <italic>in
vitro</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>JIA</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref><xref ref-type="author-notes" rid="con"><sup>#</sup></xref></contrib><contrib contrib-type="author"><name><surname>XU</surname><given-names>Ruiguang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="con"><sup>#</sup></xref></contrib><contrib contrib-type="author"><name><surname>HU</surname><given-names>Yanchun</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref><xref ref-type="author-notes" rid="con"><sup>#</sup></xref></contrib><contrib contrib-type="author"><name><surname>ZHU</surname><given-names>Tianlong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>MA</surname><given-names>Tingting</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>WU</surname><given-names>Haihong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>HU</surname><given-names>Liwen</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1"><label>1)</label>Agricultural and Environmental Branch, Jiaxing Vocational
Technical College, Zhejiang Province, Jiaxing 314036, China</aff><aff id="aff2"><label>2)</label>Key Laboratory of Animal Disease and Human Health of Sichuan
Province, College of Veterinary Medicine, Sichuan Agricultural University, Sichuan
Province, Wenjiang 611130, China</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Jia,Y., Agricultural and Environmental
Branch, Jiaxing Vocational Technical College, Zhejiang Province, Jiaxing 314036, China.
e-mail: <email xlink:href="jiayan2016@126.com">jiayan2016@126.com</email>, Hu,Y., Key
Laboratory of Animal Disease and Human Health of Sichuan Province, College of Veterinary
Medicine, Sichuan Agricultural University, Sichuan Province, Wenjiang 611130, China.
e-mail: <email xlink:href="hychun114@163.com">hychun114@163.com</email></corresp><fn id="con"><label>#</label><p>Jia, Y., Xu, R. and Hu, Y. contributed equally to this work and should be
considered as first authors.</p></fn></author-notes><pub-date pub-type="epub"><day>20</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2016</year></pub-date><volume>78</volume><issue>5</issue><fpage>819</fpage><lpage>824</lpage><history><date date-type="received"><day>30</day><month>9</month><year>2015</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9;2016 The Japanese Society of Veterinary Science</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>The purpose of this study was to investigate the anti-Newcastle disease virus (NDV)
activities of baicalin from <italic>Scutellaria baicalensis</italic>, a Traditional
Chinese Medicine <italic>in vitro</italic>. Chicken embryo fibroblasts (CEFs) were
infected with NDV, and quantitative analysis of apoptotic cells was performed using flow
cytometry. Cytotoxicity and anti-viral activities of baicalin were studied using the MTT
method. The results showed that the maximal safe concentrations of baicalin to CEFs was 1
&#x000d7; 2<sup>&#x02212;2</sup> mg/m<italic>l</italic>. Baicalin could directly kill NDV, inhibit the
infectivity of NDV to CEF and block intracellular NDV. It inhibited the apoptosis of
NDV-infected CEFs and suppressed the spread of NDV. These results indicate that baicalin
has strong anti-NDV activity and has the potential for use as components of an antiviral
drug.</p></abstract><kwd-group><kwd>apoptosis</kwd><kwd>Baicalin</kwd><kwd>newcastle disease virus (NDV)</kwd><kwd>Virus inhibitory rate</kwd></kwd-group></article-meta></front><body><p>Traditional Chinese Medicine (TCM) is a complete and independent medical system, which has
been used to diagnose, treat and prevent illnesses for thousands of years. Since the World
Health Organization began exploring TCM in the 1950s, TCM has garnered increasing interest
beyond China because of its particular therapeutic methods and effects. Currently, in many
countries, TCM provides patients with a new array of therapeutic options [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r11" ref-type="bibr">11</xref>]. In recent
years, it has been proved that many TCMs and their ingredients possess antiviral effects
[<xref rid="r15" ref-type="bibr">15</xref>]. Some TCMs and their extracts, such as
shuanghuanglian injections, a common patented Chinese drug, have been developed into antiviral
agents. TCM has many biological activities, such as adjusting immunologic function [<xref rid="r18" ref-type="bibr">18</xref>], inhibiting viral proliferation and contributing to
infection processes (adsorption, transcription, replication and release) [<xref rid="r5" ref-type="bibr">5</xref>], and provides reliable biological functions with little
side effects and low toxicity. However, TCM also has many antiviral active materials and is
rarely used in animal medicine today.</p><p>Baicalin (5,6,7-trihydroxyflavone) is one of the main active ingredients derived from the
dried root of <italic>Scutellaria baicalensis</italic>, a popular herb in TCM used as an
anti-pyretic [<xref rid="r16" ref-type="bibr">16</xref>]. It is a small-molecule monomer and
exhibits anti-inflammatory [<xref rid="r13" ref-type="bibr">13</xref>], anti-oxidant,
anti-apoptotic [<xref rid="r12" ref-type="bibr">12</xref>], anti-viral [<xref rid="r20" ref-type="bibr">20</xref>], anti-asthmatic [<xref rid="r17" ref-type="bibr">17</xref>] and
antibacterial properties [<xref rid="r34" ref-type="bibr">34</xref>]. Baicalin has
demonstrated an ability to inhibit influenza A (H1N1) infection <italic>in vitro</italic> and
protect cells from apoptosis damage through regulation of the cell cycle and suppression of
the activation of caspase-8 and caspase-3. Downregulation of caspase-8 and caspase-3 is
significant and shows a dose-dependent relationship [<xref rid="r30" ref-type="bibr">30</xref>].</p><p>Newcastle disease (ND) is a highly contagious disease in chickens. It affects more than 250
bird species and typically manifests with respiratory, gastrointestinal and/or nervous system
symptoms. The most severe form of Newcastle disease can result in mortality rates exceeding
90% in susceptible chicken flocks. The Newcastle disease virus (NDV) causes significant
economic losses worldwide every year [<xref rid="r22" ref-type="bibr">22</xref>]. Thus far,
this disease was mainly controlled with ND vaccines. Antiviral treatments are not available in
poultry owing to their cost and toxicity, and thus, a promising alternative is the use of
compounds of natural origin, which have been underexplored for this purpose [<xref rid="r28" ref-type="bibr">28</xref>]. Some Chinese veterinary herbal medical preparations,
such as Shuanghuanglian injection, and injection of <italic>Astragalus</italic>
polysaccharides have become one of the principal weapons in veterinary clinical therapy and
play an important role in clinical epidemic prevention [<xref rid="r31" ref-type="bibr">31</xref>]. However, these preparations have not displayed satisfactory clinical effects
for ND. Research and development of effective clinical medicines are still one of the primary
tasks of many veterinary researchers.</p><p>The purpose of the present study is to investigate the anti-viral properties of baicalin and
its mechanism of activity against NDV (La Sota strain IV).</p><sec sec-type="materials|methods" id="s1"><title>MATERIALS AND METHODS</title><p><italic>Equipment and reagents</italic>: Baicalin was purchased from Shanghai Jinsui
Bio-Technology Co., Ltd., Shanghai, China), purity &#x02265;98%. The carbon dioxide (CO<sub>2</sub>)
incubator was purchased from Thermo Fisher Scientific (Shanghai, China). The flow cytometry
was purchased from BD Biosciences (Shanghai, China). Unless otherwise stated, all other
reagents were from Sigma-Aldrich (Shanghai, China).</p><p><italic>Cells and virus</italic>: The chicken embryo fibroblasts (CEFs) were prepared using
10-day-old specific pathogen free chicken embryos. The chick embryo was removed right after
the eggshell was disinfected and opened. The head, extremities and viscera were removed,
washed with phosphate buffered solution (PBS), cut into 1- to 2-mm<sup>3</sup> pieces and
washed three times with PBS. A 0.25% trypsin solution was added to the samples for 30 min at
37&#x000b0;C, and then, the samples were centrifuged. The precipitate was washed three times with
PBS and filtered through a 4-tier gauze. Cells were counted and diluted into 1 &#x000d7;
10<sup>6</sup> m<italic>l</italic><sup>&#x02212;1</sup> with 10% Dulbecco&#x02019;s modified Eagle&#x02019;s
medium (DMEM) and inoculated in 96-well culture plates at 37&#x000b0;C in a humid atmosphere of 5%
CO<sub>2</sub> for 12 hr.</p><p>The strain of NDV (La Sota strain IV) propagated in the 10-day-old specific pathogen-free
chicken embryos, was obtained from the Poultry Research Laboratory of Sichuan Agricultural
University. The virus was stored at &#x02212;80&#x000b0;C until use.</p><p><italic>Virulence of NDV assay</italic>: The virulence of NDV was expressed as median
tissue culture infective dose (TCID<sub>50</sub>). NDV was prepared by 10-fold dilution
(10<sup>&#x02212;1</sup>&#x02013;10<sup>&#x02212;8</sup>). Then, 100 <italic>&#x000b5;l</italic> of viral solution was
added to each well of 96-well plates containing CEF monolayers (four wells for each
concentration). CEF, added to 100-<italic>&#x000b5;l </italic>DMEM basal medium with 2
<italic>&#x000b5;l</italic>/m<italic>l</italic> TPCK-trypsin, was used as the control. After 2 hr
of incubation at 37&#x000b0;C, 100 <italic>&#x000b5;l</italic> of DMEM basal medium with 2
<italic>&#x000b5;l</italic>/m<italic>l</italic> TPCK-trypsin was added to each well. After 72 hr,
the cytopathic effect was observed and recorded, and the TCID<sub>50</sub> value of NDV was
calculated using the Reed-Muench formula.</p><p><italic>Cytotoxicity analysis</italic>: Baicalin was diluted two-fold serially from 2
mg/m<italic>l</italic> to eight concentrations with DMEM. CEFs were prepared and
cultivated in 96-well plates. CEF monolayers in the 96-well plates were exposed to baicalin
at a series of concentrations (four wells each concentration). After culture for 72 hr in a
37&#x000b0;C humid atmosphere of 5% CO<sub>2</sub>, 30 <italic>&#x000b5;l</italic> of MTT was added to each
well and incubated for 4 hr. The supernatant was then removed and 100 <italic>&#x000b5;l</italic> of
dimethyl sulfoxide (DMSO) was added to each well. The plates were shaken for 10 min to
dissolve the crystals completely. The absorbance at 570 nm (A570 value) was measured using a
microliter enzyme-linked immunosorbent assay reader. Larger A570 values contribute to more
live cells, since A570 values are correlated with the number of live cells. When the A570
values of the Chinese crude drug group were not significantly lower than that of the cells
in the control group (indicating that the Chinese crude drugs had no cytotoxicity), the
corresponding concentrations were considered a maximally safe concentration for CEFs. All
experiments were carried out in triplicate [<xref rid="r3" ref-type="bibr">3</xref>].</p><p><italic>Antiviral assay</italic>: According to the results of the cytotoxicity analysis,
baicalin at eight different concentrations, from 250 to 1.953
<italic>&#x000b5;</italic>g/m<italic>l,</italic> was used for determination of anti-viral activity
using the MTT method. When treating CEFs cultured in monolayers, the two-fold serial
dilutions of Chinese crude drugs and 100 TCID<sub>50</sub> NDV were added to the cell
plates, respectively, using three different methods:</p><p>Pre-addition of the drug: Baicalin solution was first added to CEFs at 100
<italic>&#x000b5;l</italic> per well (four wells per concentration). After incubation for 4 hr,
the baicalin solution was removed, cells were washed twice with PBS, and 100
<italic>&#x000b5;l</italic> of the virus solution was added to each well.</p><p>Post-addition of the drug: The virus solution was added to the CEFs first. After incubation
for 2 hr, baicalin solution was removed, cells were washed twice with PBS, and baicalin
solution was added to the wells (four wells each concentration).</p><p>Simultaneous-addition of the drug and virus after mixing: Each concentration of baicalin
solution was mixed with the virus solution, incubated for 2 hr at 37&#x000b0;C and then added to the
CEFs (four wells for each concentration). At the same time, the NDV control group (virus
only), cell control group (DMEM only) and the black group (no cells) were established [<xref rid="r32" ref-type="bibr">32</xref>].</p><p>All CEF plates were placed in a 5% CO<sub>2</sub> incubator at 37&#x000b0;C. After 72 hr when the
NDV control group showed the appearance of cytopathic effect (CPE), the CEF viability was
measured using the MTT assay [<xref rid="r26" ref-type="bibr">26</xref>]. The mean cellular
A570 values were used as indices of anti-viral activity. Baicalin was considered to have
significant anti-viral activity when the A570 value of the Chinese crude drug group was
significantly higher than that of the virus control group was [<xref rid="r14" ref-type="bibr">14</xref>].</p><p>The virus inhibitory rate was calculated based on the formula [<xref rid="r10" ref-type="bibr">10</xref>]: Virus inhibitory rate=(the highest &#x00100;570 value of baicalin group
&#x02212;&#x00100;570 value of the virus control group)/(&#x00100;570 value of the cell control group &#x02212;&#x00100;570 value of
the virus control group)&#x000d7;100%.</p><p><italic>Flow cytometry analysis of apoptosis (FACS)</italic>: The CEFs were inoculated in
6-well culture plates at 37&#x000b0;C in a humid atmosphere of 5% CO<sub>2</sub> until they were
cultured into a monolayer. A 100 TCID<sub>50</sub> virus solution was added to the CEFs.
After incubation for 2 hr at 37&#x000b0;C, the virus solution was removed, the cells were washed
twice with PBS, and the maximal safe concentration of the baicalin solution was added (three
wells for each concentration). At the same time, the NDV control group (virus only) and the
cell control group (DMEM only) were established. All CEF plates were placed in a 5%
CO<sub>2</sub> incubator at 37&#x000b0;C for 72 hr until the NDV control group had the appearance
of CPE.</p><p>Each group was collected by trypsinization, washed twice with PBS, resuspended in one time
binding buffer at a concentration of 1 &#x000d7; 10<sup>6</sup> cells/m<italic>l</italic> and
subjected to Annexin V-FITC/PI staining. The samples were analyzed by FACS and Cell Quest
Research Software [<xref rid="r4" ref-type="bibr">4</xref>].</p><p><italic>Statistical analysis</italic>: Data were expressed as mean&#x000b1; standard error (SE),
and Duncan&#x02019;s multiple range test was used to analyze the difference among the Chinese crude
drug and control groups. Differences between means were considered significant at
<italic>P</italic>&#x0003c;0.05.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><p><italic>The cytotoxicity of baicalin to CEFs</italic>: The A570 values of each group are
listed in <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>The cytotoxicity of Baicalin to CEF (A570 value)</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Concentration (mg/m<italic>l</italic>)</th><th valign="middle" align="center" rowspan="1" colspan="1">Baicalin (A570)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.211 &#x000b1; 0.007<sup>d)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2&#x000b0;</td><td align="center" valign="middle" rowspan="1" colspan="1">0.347 &#x000b1; 0.009<sup>c)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;1</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.421 &#x000b1; 0.007<sup>b)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.472 &#x000b1; 0.011<sup>a)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.477 &#x000b1; 0.015<sup>a)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.481 &#x000b1; 0.007<sup>a)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.479 &#x000b1; 0.004<sup>a)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.477 &#x000b1; 0.007<sup>a)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cell control</td><td align="center" valign="middle" rowspan="1" colspan="1">0.471 &#x000b1; 0.007<sup>a)</sup></td></tr></tbody></table><table-wrap-foot><p>Data are shown as the mean &#x000b1; SE. a&#x02013;d) Data within a column without the same
superscripts <italic>P</italic>&#x0003c;0.05.</p></table-wrap-foot></table-wrap>. The A570 values of baicalin in the 1 &#x000d7; 2<sup>&#x02212;2</sup> mg/m<italic>l</italic>
groups were not significantly lower than those of the corresponding cell control groups
(<italic>P</italic> &#x0003e;0.05). Therefore, these concentrations could be considered as the
maximum safe concentrations.</p><p><italic>Antiviral activity of baicalin in CEF</italic>:</p><p>(1) Antiviral activity of baicalin before addition of the drug</p><p>The A570 values and the virus inhibition rates of each group are listed in <xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Effect of Baicalin on blocking, neutralizing and inhibiting NDV</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" colspan="1">Concentration<break/>(mg/m<italic>l</italic>)</th><th colspan="2" align="center" valign="middle" rowspan="1">Block</th><th colspan="2" align="center" valign="middle" rowspan="1">Neutralize</th><th colspan="2" align="center" valign="middle" rowspan="1">Inhibit</th></tr><tr><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">Baicalin (A570)</th><th align="center" valign="middle" rowspan="1" colspan="1">Blocking rate</th><th align="center" valign="middle" rowspan="1" colspan="1">Baicalin (A570)</th><th align="center" valign="middle" rowspan="1" colspan="1">Neutralization rate</th><th align="center" valign="middle" rowspan="1" colspan="1">Baicalin (A570)</th><th align="center" valign="middle" rowspan="1" colspan="1">Inhibition rate</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.446 &#x000b1; 0.005<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">100.00%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.447 &#x000b1; 0.007<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">100.41%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.455 &#x000b1; 0.006<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">103.70%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.443 &#x000b1; 0.010<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">98.77%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.445 &#x000b1; 0.006<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">99.59%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.450 &#x000b1; 0.008<sup>a, b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">101.65%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;4</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.443 &#x000b1; 0.007<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">98.77%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.437 &#x000b1; 0.005<sup>a, b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">96.30%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.449 &#x000b1; 0.006<sup>a, b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">101.23%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.430 &#x000b1; 0.004<sup>b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">93.42%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.425 &#x000b1; 0.007<sup>b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">91.36%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.447 &#x000b1; 0.009<sup>a, b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">100.41%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;6</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.429 &#x000b1; 0.008<sup>b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">93.00%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.412 &#x000b1; 0.004<sup>c)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">86.01%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.443 &#x000b1; 0.005<sup>a, b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">98.77%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;7</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.406 &#x000b1; 0.008<sup>c)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">83.54%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.397 &#x000b1; 0.005<sup>d)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">79.84%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.444 &#x000b1; 0.008<sup>a, b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">99.18%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;8</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.372 &#x000b1; 0.011<sup>d)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">69.55%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.381 &#x000b1; 0.004<sup>e)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">73.25%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.432 &#x000b1; 0.009<sup>b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">94.24%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x000d7; 2<sup>&#x02212;9</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.345 &#x000b1; 0.006<sup>e)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">58.44%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.365 &#x000b1; 0.007<sup>f)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">66.67%</td><td align="center" valign="middle" rowspan="1" colspan="1">0.422 &#x000b1; 0.008<sup>b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">90.12%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cell control</td><td align="center" valign="middle" rowspan="1" colspan="1">0.446 &#x000b1; 0.008<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.446 &#x000b1; 0.008<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.446 &#x000b1; 0.008<sup>a, b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NDV control</td><td align="center" valign="middle" rowspan="1" colspan="1">0.203 &#x000b1; 0.008<sup>f)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.203 &#x000b1; 0.008<sup>g)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.203 &#x000b1; 0.008<sup>c)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><p>Data are shown as the mean &#x000b1; SE. a&#x02013;g) Data within a column without the same
superscripts <italic>P</italic>&#x0003c;0.05.</p></table-wrap-foot></table-wrap>. The A570 values of baicalin in the 1 &#x000d7; 2<sup>&#x02212;9</sup>&#x02013;1 &#x000d7; 2<sup>&#x02212;2</sup>
mg/m<italic>l</italic> groups were significantly higher than the A570 values of the NDV
control groups were (<italic>P</italic>&#x0003c;0.05). The highest virus inhibitory rates of the
baicalin groups were 100%.</p><p>(2) Antiviral activity of Baicalin in post-addition of the drug</p><p>The A570 values and the virus inhibition rates of each group are listed in <xref rid="tbl_002" ref-type="table">Table 2</xref>. The A570 values of baicalin in the 1 &#x000d7;
2<sup>&#x02212;9</sup>&#x02013;1 &#x000d7; 2<sup>&#x02212;2</sup> mg/m<italic>l</italic> groups were significantly higher
than the A570 values of the NDV control groups were (<italic>P</italic>&#x0003c;0.05). The
highest virus inhibition rates of the baicalin groups were &#x0003e;100%.</p><p>(3) Antiviral activity of baicalin in simultaneous-addition of the drug and virus after
mixing</p><p>The A570 values and the virus neutralization rates of each group are listed in <xref rid="tbl_002" ref-type="table">Table 2</xref>. The A570 values of baicalin in the 1 &#x000d7;
2<sup>&#x02212;9</sup>&#x02013;1 &#x000d7; 2<sup>&#x02212;2</sup> mg/m<italic>l</italic> groups were significantly higher
than the A570 values of the NDV control groups were (<italic>P</italic>&#x0003c;0.05). The
highest virus neutralization rates of the baicalin groups were higher than 100%.</p><p><italic>Annexin V-FITC/PI staining</italic>: FACS was used in the quantitative analysis of
apoptotic cells after NDV infection by staining cells with a combination of fluorescent
Annexin V-FITC and PI (<xref rid="tbl_003" ref-type="table">Table 3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>The Apoptosis rates of treatment groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" colspan="1">Classification</th><th colspan="2" align="center" rowspan="1">Apoptosis rates (%)</th></tr><tr><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Early stage</th><th align="center" rowspan="1" colspan="1">Late stage</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Baicalin</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">18.17 &#x000b1; 0.61<sup>c)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">27.33 &#x000b1; 0.71<sup>b)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cells control</td><td align="center" valign="middle" rowspan="1" colspan="1">20.75 &#x000b1; 0.74<sup>b)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">27.37 &#x000b1; 0.59<sup>b)</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NDV control</td><td align="center" valign="middle" rowspan="1" colspan="1">24.52 &#x000b1; 0.72<sup>a)</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">36.2 &#x000b1; 0.65<sup>a)</sup></td></tr></tbody></table><table-wrap-foot><p>Data are shown as the mean &#x000b1; SE. a&#x02013;c) Data within a column without the same
superscripts <italic>P</italic>&#x0003c;0.01.</p></table-wrap-foot></table-wrap>, <xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Flow cytometry analysis of Annexin V/PI assay. In the four quadrants for each image,
the right lower quadrant is for the early apoptosis rate, and the right upper quadrant
is for the late apoptosis rate. A: Cell control; B: NDV control; C: CEFs treated with
the maximum safe concentration of baicalin and 100 pfu/well of NDV.</p></caption><graphic xlink:href="jvms-78-819-g001"/></fig>). The early and late stage apoptosis rates of the cell control groups were 20.75% and
27.37%, respectively. The early and late apoptosis rates of NDV control groups were 24.52%
and 36.20%, respectively. The early and late apoptosis rates of the maximum concentration
for the baicalin groups were 18.17% and 27.33%, respectively.</p></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>The cell absorbance value (A570 value) is an index that reflects the number of living cells
and is related to cell growth. A higher value of A570 indicates higher activity of CEF
[<xref rid="r19" ref-type="bibr">19</xref>]. In this study, a high A570 value reflected
good anti-viral activity of the Chinese crude drugs. The Chinese crude drugs were indicated
to have no cytotoxicity when their A570 values were not significantly lower than those of
control group were, and the corresponding concentration could be considered as the maximally
safe concentration for CEFs. The results of the safe concentration indicated that at
baicalin concentrations higher than 1 &#x000d7; 2<sup>&#x02212;2</sup> mg/m<italic>l</italic>, cell growth
was inhibited. Baicalin, within a certain range of concentrations, demonstrated
cytotoxicity.</p><p>The virus inhibitory rate directly reflects the antiviral potential of a drug [<xref rid="r10" ref-type="bibr">10</xref>]. The pre-addition of baicalin was thought to exert
inhibitory action at a very early stage in the viral infection cycle as the virus adsorbs or
penetrates into the host cell [<xref rid="r25" ref-type="bibr">25</xref>]. NDV infection is
achieved via two envelope proteins, hemagglutinin-neuraminidase (HN) and the fusion protein
(F) [<xref rid="r7" ref-type="bibr">7</xref>]. HN binds to sialic acid-containing receptors,
leading to virus adsorption, and promotes membrane fusion causing virus penetration into
host cells [<xref rid="r8" ref-type="bibr">8</xref>]. There are two sialic acid binding
sites on the globular head region of HN [<xref rid="r29" ref-type="bibr">29</xref>]. Our
results showed that the A570 values of all eight concentrations of the baicalin groups were
significantly higher than the A570 values of the corresponding virus control groups were,
which indicated that they could prevent NDV infection. Baicalin could block HN binding to
sialic acid-containing receptors and virus adsorption.</p><p>The post-addition of Chinese crude drugs was thought to prevent viral protein synthesis. It
may affect the transmembrane and intracellular signaling processes involved in regulating
virus expression. These results were supported by previous findings that viral protein
synthesis was prevented by carrageenan, as inhibition was observed only when the compound
was present during virus entry [<xref rid="r23" ref-type="bibr">23</xref>]. Damonte
<italic>et al.</italic> reported that the few attempts had been made to find anti-viral
substances by mainly focusing on the screening of probable ribonucleic acid (RNA) synthesis
inhibitors, such as ribavirin and other nucleoside analogs [<xref rid="r9" ref-type="bibr">9</xref>]. In agreement with this idea, our results showed that the A570 values of all
eight concentrations of the baicalin groups were significantly higher than the A570 values
of the corresponding virus control groups, which indicated that they could treat the NDV
infection. Baicalin could inhibit viral protein or RNA synthesis.</p><p>The mixed-addition of Chinese crude drugs and viruses was thought to cause direct
inactivation of the viruses. Wang <italic>et al.</italic> reported that sulfated
<italic>Lycium barbarum</italic> polysaccharide at certain concentrations could directly
kill NDV [<xref rid="r27" ref-type="bibr">27</xref>]. In agreement with this idea, our
results showed that the A570 values of all eight concentrations of the baicalin groups were
significantly higher than the A570 values of the corresponding virus control groups were,
which indicated that they could directly kill NDV.</p><p>The NDV inhibitory rate of baicalin decreased in a dose-dependent manner. Both of the
blocking rate and neutralization rate are significantly decreased as the decrease of the
baicalin concentrations, but the inhibition rate is slightly decreased as the decrease of
the baicalin concentrations. High concentrations of baicalin in the all three methods of
addition, such as 1 &#x000d7; 2<sup>&#x02212;2</sup> mg/m<italic>l</italic>, 1 &#x000d7; 2<sup>&#x02212;3</sup>
mg/m<italic>l</italic> and 1 &#x000d7; 2<sup>&#x02212;4</sup> mg/m<italic>l</italic>, had strong effects
on NDV. However, low concentrations of baicalin in combination with the
simultaneous-addition of the drug and virus after mixing, such as 1 &#x000d7; 2<sup>&#x02212;7</sup>
mg/m<italic>l</italic>, 1 &#x000d7; 2<sup>&#x02212;8</sup> mg/m<italic>l</italic> and 1 &#x000d7; 2<sup>&#x02212;9</sup>
mg/m<italic>l</italic>, had the strongest effect in directly killing NDV of the three
methods of addition.</p><p>The highest virus inhibitory rate directly reflected the anti-viral potency. The highest
virus inhibition rates and the highest virus neutralization rates of the baicalin groups
were both higher than 100%. Our results showed that baicalin could suppress NDV as well as
lead to CEF growth and proliferation. Zhao <italic>et al.</italic> reported that baicalin
could promote CEF growth significantly [<xref rid="r33" ref-type="bibr">33</xref>]. This
view is consistent with the results of our study.</p><p>NDV can induce apoptosis of infected CEF. To investigate the anti-viral mechanism of
baicalin, we evaluated the apoptosis of CFE by flow cytometry (FCM) [<xref rid="r6" ref-type="bibr">6</xref>]. Our results showed that baicalin could inhibit NDV-infected CEF
apoptosis in both early and late stages of the infection process. The stages of apoptosis
can be categorized into early and late, and the sum of the stages represents the total
apoptosis rate. NDV induces apoptosis in cells through caspase- and p38-MAPK-dependent
pathways [<xref rid="r2" ref-type="bibr">2</xref>]. Baicalin may inhibit NDV-infected CEF
apoptosis by blocking the signaling pathway and thus, reduce the release of NDV.</p><p>In recent years, the inhibitory effect of some TCM against NDV has been studied. Zhang
<italic>et al.</italic> reported that some flavone ingredients from TCM could inhibit
NDV-infected cells, such as baical skullcap root flavones, wild dendranthema flower
flavones, epimedium flavones and sanchi flavones. However, their toxicity is higher than
that of baicalin is, and only flavone prescriptions with suitable compatibility can show
good anti-viral activity [<xref rid="r31" ref-type="bibr">31</xref>]. Some polysaccharides
from TCM also could inhibit NDV infection of cells, such as <italic>Chuanmingshen
violaceum</italic> polysaccharide, <italic>Auricularia auricula</italic> polysaccharide
and <italic>Tremella</italic> polysaccharide. Anti-viral activity of these polysaccharides
is insufficient, but sulfation could increase their anti-NDV activity [<xref rid="r21" ref-type="bibr">21</xref>, <xref rid="r24" ref-type="bibr">24</xref>, <xref rid="r32" ref-type="bibr">32</xref>].</p><p>In conclusion, baicalin can suppress, neutralize and block NDV <italic>in vitro</italic>,
as well inhibit NDV-infected CEF apoptosis, leading to the subsequent suppression of the
spreading of NDV infection. The compound has potential for use as components of future
anti-viral regimens.</p></sec></body><back><ack><p>This research was partially supported by the Science and Technology
Support Program of Sichuan Province (Grant No.2015SZ0201) and Veterinary herbal immune
technology research and innovation team of Jiaxing Vocational and Technical College
[No.Jiazhiyuan (2012) 74].</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Andrews</surname><given-names>G. J.</given-names></name><name><surname>Evans</surname><given-names>J.</given-names></name><name><surname>McAlister</surname><given-names>S.</given-names></name></person-group><year>2013</year>. <article-title>&#x02018;Creating the right therapy vibe&#x02019;:
relational performances in holistic medicine</article-title>. <source><italic>Soc. Sci.
Med.</italic></source><volume>83</volume>: <fpage>99</fpage>&#x02013;<lpage>109</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.socscimed.2013.01.008</pub-id><pub-id pub-id-type="pmid">23395345</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Bian</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Jiao</surname><given-names>X.</given-names></name><name><surname>Ge</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Meng</surname><given-names>S.</given-names></name></person-group><year>2011</year>. <article-title>Caspase- and p38-MAPK-dependent induction
of apoptosis in A549 lung cancer cells by Newcastle disease virus</article-title>.
<source><italic>Arch. Virol.</italic></source><volume>156</volume>:
<fpage>1335</fpage>&#x02013;<lpage>1344</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00705-011-0987-y</pub-id><pub-id pub-id-type="pmid">21625975</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Chen</surname><given-names>M. Z.</given-names></name><name><surname>Xie</surname><given-names>H. G.</given-names></name><name><surname>Yang</surname><given-names>L. W.</given-names></name><name><surname>Liao</surname><given-names>Z. H.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name></person-group><year>2010</year>. <article-title><italic>In vitro</italic> anti-influenza
virus activities of sulfated polysaccharide fractions from Gracilaria
lemaneiformis</article-title>. <source><italic>Virol.
Sin.</italic></source><volume>25</volume>: <fpage>341</fpage>&#x02013;<lpage>351</lpage>. doi:
<pub-id pub-id-type="doi">10.1007/s12250-010-3137-x</pub-id><pub-id pub-id-type="pmid">20960180</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Cheng</surname><given-names>A. C.</given-names></name><name><surname>Wang</surname><given-names>M. S.</given-names></name><name><surname>Chen</surname><given-names>X. Y.</given-names></name></person-group><year>2008</year>
<article-title>Dynamic changes of apoptosis in duck
embryo fibroblasts induced by new type Gosling viral enteritis virus</article-title>.
<source><italic>Prog. Nat. Sci.</italic></source><volume>18</volume>:
<fpage>239</fpage>&#x02013;<lpage>244</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pnsc.2007.08.005</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name></person-group><year>2013</year>. <article-title>Anti-HBV effect of individual traditional
Chinese herbal medicine <italic>in vitro</italic> and <italic>in vivo</italic>: an
analytic review</article-title>. <source><italic>J. Viral
Hepat.</italic></source><volume>20</volume>: <fpage>445</fpage>&#x02013;<lpage>452</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/jvh.12112</pub-id><pub-id pub-id-type="pmid">23730837</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Cong</surname><given-names>X. M.</given-names></name><name><surname>Niu</surname><given-names>L.</given-names></name><name><surname>Bai</surname><given-names>X. Y.</given-names></name><name><surname>Wu</surname><given-names>C. H.</given-names></name><name><surname>Sun</surname><given-names>Y. G.</given-names></name><name><surname>He</surname><given-names>J. P.</given-names></name><name><surname>Bai</surname><given-names>Y. S.</given-names></name><name><surname>Li</surname><given-names>H. Q.</given-names></name></person-group><year>2013</year>
<article-title>Dipotassium glycyrrhizinate against MDV
on CEFs by promoting MDV-Infected cells apoptosis <italic>in
vitro</italic></article-title>. <source><italic>Sci. Agric.
Sin.</italic></source><volume>46</volume>:
<fpage>3914</fpage>&#x02013;<lpage>3921</lpage>.</mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Connaris</surname><given-names>H.</given-names></name><name><surname>Takimoto</surname><given-names>T.</given-names></name><name><surname>Russell</surname><given-names>R.</given-names></name><name><surname>Crennell</surname><given-names>S.</given-names></name><name><surname>Moustafa</surname><given-names>I.</given-names></name><name><surname>Portner</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>G.</given-names></name></person-group><year>2002</year>. <article-title>Probing the sialic acid binding site of
the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino
acids involved in cell binding, catalysis, and fusion</article-title>.
<source><italic>J. Virol.</italic></source><volume>76</volume>:
<fpage>1816</fpage>&#x02013;<lpage>1824</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.76.4.1816-1824.2002</pub-id><pub-id pub-id-type="pmid">11799177</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Crennell</surname><given-names>S.</given-names></name><name><surname>Takimoto</surname><given-names>T.</given-names></name><name><surname>Portner</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>G.</given-names></name></person-group><year>2000</year>. <article-title>Crystal structure of the multifunctional
paramyxovirus hemagglutinin-neuraminidase</article-title>. <source><italic>Nat. Struct.
Biol.</italic></source><volume>7</volume>: <fpage>1068</fpage>&#x02013;<lpage>1074</lpage>.
doi: <pub-id pub-id-type="doi">10.1038/81002</pub-id><pub-id pub-id-type="pmid">11062565</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Damonte</surname><given-names>E. B.</given-names></name><name><surname>Pujol</surname><given-names>C. A.</given-names></name><name><surname>Coto</surname><given-names>C. E.</given-names></name></person-group><year>2004</year>. <article-title>Prospects for the therapy and prevention
of dengue virus infections</article-title>. <source><italic>Adv. Virus
Res.</italic></source><volume>63</volume>: <fpage>239</fpage>&#x02013;<lpage>285</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/S0065-3527(04)63004-1</pub-id><pub-id pub-id-type="pmid">15530563</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name></person-group><year>2011</year>. <article-title>Epimedium polysaccharide and propolis
flavone can synergistically inhibit the cellular infectivity of NDV and improve the
curative effect of ND in chicken</article-title>. <source><italic>Int. J. Biol.
Macromol.</italic></source><volume>48</volume>: <fpage>439</fpage>&#x02013;<lpage>444</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2011.01.005</pub-id><pub-id pub-id-type="pmid">21238483</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Yin</surname><given-names>N.</given-names></name><name><surname>Pei</surname><given-names>J.</given-names></name><name><surname>Lai</surname><given-names>L.</given-names></name></person-group><year>2013</year>. <article-title>Understanding molecular mechanisms of
traditional Chinese medicine for the treatment of influenza viruses infection by
computational approaches</article-title>. <source><italic>Mol.
Biosyst.</italic></source><volume>9</volume>: <fpage>2696</fpage>&#x02013;<lpage>2700</lpage>.
doi: <pub-id pub-id-type="doi">10.1039/c3mb70268e</pub-id><pub-id pub-id-type="pmid">23986228</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Guo</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>E.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name></person-group><year>2013</year>
<article-title>Baicalin inhibits S. aureus-induced
apoptosis by regulating TLR2 and TLR2-related apoptotic factors in the mouse mammary
glands</article-title>. <source><italic>Eur. J.
Pharmacol.</italic></source><volume>723</volume>:
<fpage>125</fpage>&#x02013;<lpage>130</lpage>.</mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Guo</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Liang</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name></person-group><year>2013</year>. <article-title>Baicalin plays an anti-inflammatory role
through reducing nuclear factor-&#x003ba;B and p38 phosphorylation in S. aureus-induced
mastitis</article-title>. <source><italic>Int.
Immunopharmacol.</italic></source><volume>16</volume>:
<fpage>125</fpage>&#x02013;<lpage>130</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2013.03.006</pub-id><pub-id pub-id-type="pmid">23523628</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name></person-group><year>2008</year>. <article-title>Effect of sulfated astragalus
polysaccharide on cellular infectivity of infectious bursal disease
virus</article-title>. <source><italic>Int. J. Biol.
Macromol.</italic></source><volume>42</volume>: <fpage>166</fpage>&#x02013;<lpage>171</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2007.10.019</pub-id><pub-id pub-id-type="pmid">18061660</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Peng</surname><given-names>T.</given-names></name></person-group><year>2013</year>. <article-title>Traditional Chinese herbal medicine as a
source of molecules with antiviral activity</article-title>. <source><italic>Antiviral
Res.</italic></source><volume>97</volume>: <fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.antiviral.2012.10.006</pub-id><pub-id pub-id-type="pmid">23153834</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Li-Weber</surname><given-names>M.</given-names></name></person-group><year>2009</year>. <article-title>New therapeutic aspects of flavones: the
anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein
and Baicalin</article-title>. <source><italic>Cancer Treat.
Rev.</italic></source><volume>35</volume>: <fpage>57</fpage>&#x02013;<lpage>68</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.ctrv.2008.09.005</pub-id><pub-id pub-id-type="pmid">19004559</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Ma</surname><given-names>C.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Fu</surname><given-names>Q.</given-names></name><name><surname>Ma</surname><given-names>S.</given-names></name></person-group><year>2014</year>. <article-title>Anti-asthmatic effects of baicalin in a
mouse model of allergic asthma</article-title>. <source><italic>Phytother.
Res.</italic></source><volume>28</volume>: <fpage>231</fpage>&#x02013;<lpage>237</lpage>. doi:
<pub-id pub-id-type="doi">10.1002/ptr.4983</pub-id><pub-id pub-id-type="pmid">23580257</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Ma</surname><given-names>H. D.</given-names></name><name><surname>Deng</surname><given-names>Y. R.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Lian</surname><given-names>Z. X.</given-names></name></person-group><year>2013</year>. <article-title>Traditional Chinese medicine and immune
regulation</article-title>. <source><italic>Clin. Rev. Allergy
Immunol.</italic></source><volume>44</volume>: <fpage>229</fpage>&#x02013;<lpage>241</lpage>.
doi: <pub-id pub-id-type="doi">10.1007/s12016-012-8332-0</pub-id><pub-id pub-id-type="pmid">22826112</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>Z.</given-names></name></person-group><year>2010</year>
<article-title>Effects of sulfated polysaccharides and
their prescriptions on immune response of ND vaccine in chicken</article-title>.
<source><italic>Carbohydr. Polym.</italic></source><volume>82</volume>:
<fpage>9</fpage>&#x02013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.carbpol.2010.04.013</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Nayak</surname><given-names>M. K.</given-names></name><name><surname>Agrawal</surname><given-names>A. S.</given-names></name><name><surname>Bose</surname><given-names>S.</given-names></name><name><surname>Naskar</surname><given-names>S.</given-names></name><name><surname>Bhowmick</surname><given-names>R.</given-names></name><name><surname>Chakrabarti</surname><given-names>S.</given-names></name><name><surname>Sarkar</surname><given-names>S.</given-names></name><name><surname>Chawla-Sarkar</surname><given-names>M.</given-names></name></person-group><year>2014</year>. <article-title>Antiviral activity of baicalin against
influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune
responses</article-title>. <source><italic>J. Antimicrob.
Chemother.</italic></source><volume>69</volume>:
<fpage>1298</fpage>&#x02013;<lpage>1310</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkt534</pub-id><pub-id pub-id-type="pmid">24458510</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Nguyen</surname><given-names>T. L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Abula</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Qin</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Khakame</surname><given-names>S. K.</given-names></name><name><surname>Dang</surname><given-names>B. K.</given-names></name></person-group><year>2012</year>. <article-title><italic>In vitro</italic> antiviral
activity of sulfated Auricularia auricula polysaccharides</article-title>.
<source><italic>Carbohydr. Polym.</italic></source><volume>90</volume>:
<fpage>1254</fpage>&#x02013;<lpage>1258</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.carbpol.2012.06.060</pub-id><pub-id pub-id-type="pmid">22939338</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Palya</surname><given-names>V.</given-names></name><name><surname>Kiss</surname><given-names>I.</given-names></name><name><surname>Tat&#x000e1;r-Kis</surname><given-names>T.</given-names></name><name><surname>Mat&#x000f3;</surname><given-names>T.</given-names></name><name><surname>Felf&#x000f6;ldi</surname><given-names>B.</given-names></name><name><surname>Gardin</surname><given-names>Y.</given-names></name></person-group><year>2012</year>. <article-title>Advancement in vaccination against
Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces
challenge virus shedding with the absence of vaccine reactions</article-title>.
<source><italic>Avian Dis.</italic></source><volume>56</volume>:
<fpage>282</fpage>&#x02013;<lpage>287</lpage>. doi: <pub-id pub-id-type="doi">10.1637/9935-091511-Reg.1</pub-id><pub-id pub-id-type="pmid">22856183</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Shao</surname><given-names>Q.</given-names></name><name><surname>Guo</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>T.</given-names></name></person-group><year>2015</year>. <article-title>Specific Inhibitory Effect of
&#x003ba;-Carrageenan Polysaccharide on Swine Pandemic 2009 H1N1 Influenza
Virus</article-title>. <source><italic>PLoS ONE</italic></source><volume>10</volume>:
<fpage>e0126577</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0126577</pub-id><pub-id pub-id-type="pmid">25969984</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Cheng</surname><given-names>A.</given-names></name><name><surname>Jia</surname><given-names>R.</given-names></name><name><surname>Yuan</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>Q.</given-names></name><name><surname>Dai</surname><given-names>S.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Lv</surname><given-names>C.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Su</surname><given-names>G.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Ye</surname><given-names>G.</given-names></name><name><surname>Shi</surname><given-names>F.</given-names></name></person-group><year>2013</year>. <article-title>Antiviral activity of sulfated
Chuanmingshen violaceum polysaccharide against Newcastle disease virus</article-title>.
<source><italic>J. Gen. Virol.</italic></source><volume>94</volume>:
<fpage>2164</fpage>&#x02013;<lpage>2174</lpage>. doi: <pub-id pub-id-type="doi">10.1099/vir.0.054270-0</pub-id><pub-id pub-id-type="pmid">23884364</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Talarico</surname><given-names>L. B.</given-names></name><name><surname>Zibetti</surname><given-names>R. G. M.</given-names></name><name><surname>Faria</surname><given-names>P. C. S.</given-names></name><name><surname>Scolaro</surname><given-names>L. A.</given-names></name><name><surname>Duarte</surname><given-names>M. E. R.</given-names></name><name><surname>Noseda</surname><given-names>M. D.</given-names></name><name><surname>Pujol</surname><given-names>C. A.</given-names></name><name><surname>Damonte</surname><given-names>E. B.</given-names></name></person-group><year>2004</year>. <article-title>Anti-herpes simplex virus activity of
sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia
crenulata</article-title>. <source><italic>Int. J. Biol.
Macromol.</italic></source><volume>34</volume>: <fpage>63</fpage>&#x02013;<lpage>71</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2004.03.002</pub-id><pub-id pub-id-type="pmid">15178011</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Verma</surname><given-names>A.</given-names></name><name><surname>Prasad</surname><given-names>K. N.</given-names></name><name><surname>Singh</surname><given-names>A. K.</given-names></name><name><surname>Nyati</surname><given-names>K. K.</given-names></name><name><surname>Gupta</surname><given-names>R. K.</given-names></name><name><surname>Paliwal</surname><given-names>V. K.</given-names></name></person-group><year>2010</year>. <article-title>Evaluation of the MTT lymphocyte
proliferation assay for the diagnosis of neurocysticercosis</article-title>.
<source><italic>J. Microbiol. Methods</italic></source><volume>81</volume>:
<fpage>175</fpage>&#x02013;<lpage>178</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mimet.2010.03.001</pub-id><pub-id pub-id-type="pmid">20211664</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Abula</surname><given-names>S.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name></person-group><year>2010</year>. <article-title>Lycium barbarum polysaccharide inhibits
the infectivity of Newcastle disease virus to chicken embryo fibroblast</article-title>.
<source><italic>Int. J. Biol. Macromol.</italic></source><volume>46</volume>:
<fpage>212</fpage>&#x02013;<lpage>216</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2009.11.011</pub-id><pub-id pub-id-type="pmid">19962398</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group><name><surname>Yasuhara-Bell</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name></person-group><year>2010</year>. <article-title>Marine compounds and their antiviral
activities</article-title>. <source><italic>Antiviral
Res.</italic></source><volume>86</volume>: <fpage>231</fpage>&#x02013;<lpage>240</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.antiviral.2010.03.009</pub-id><pub-id pub-id-type="pmid">20338196</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>Zaitsev</surname><given-names>V.</given-names></name><name><surname>von Itzstein</surname><given-names>M.</given-names></name><name><surname>Groves</surname><given-names>D.</given-names></name><name><surname>Kiefel</surname><given-names>M.</given-names></name><name><surname>Takimoto</surname><given-names>T.</given-names></name><name><surname>Portner</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>G.</given-names></name></person-group><year>2004</year>. <article-title>Second sialic acid binding site in
Newcastle disease virus hemagglutinin-neuraminidase: implications for
fusion</article-title>. <source><italic>J. Virol.</italic></source><volume>78</volume>:
<fpage>3733</fpage>&#x02013;<lpage>3741</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.78.7.3733-3741.2004</pub-id><pub-id pub-id-type="pmid">15016893</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhang</surname><given-names>C. J.</given-names></name><name><surname>Gu</surname><given-names>L. G.</given-names></name><name><surname>Yu</surname><given-names>H. T.</given-names></name></person-group><year>2011</year>. <article-title>[Antagonism of baicalin on cell cyclical
distribution and cell apoptosis in A549 cells infected with influenza A (H1N1)
virus]</article-title>. <source><italic>Bing Du Xue
Bao</italic></source><volume>27</volume>: <fpage>108</fpage>&#x02013;<lpage>116</lpage>. <pub-id pub-id-type="pmid">21528534</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group><name><surname>Yuqing</surname><given-names>Z.</given-names></name><name><surname>Zhan&#x02019;ao</surname><given-names>S.</given-names></name><name><surname>Jiaguo</surname><given-names>L.</given-names></name><name><surname>Deyun</surname><given-names>W.</given-names></name><name><surname>Baokang</surname><given-names>Z.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Yunpeng</surname><given-names>F.</given-names></name><name><surname>Dan</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Yuanliang</surname><given-names>H.</given-names></name></person-group><year>2012</year>. <article-title>Flavone ingredients can synergistically
inhibit NDV infecting cell and improve ND vaccine&#x02019;s protective rate</article-title>.
<source><italic>Int. J. Biol. Macromol.</italic></source><volume>51</volume>:
<fpage>201</fpage>&#x02013;<lpage>208</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2012.04.028</pub-id><pub-id pub-id-type="pmid">22575392</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Abula</surname><given-names>S.</given-names></name></person-group><year>2011</year>. <article-title>Optimization of sulfated modification
conditions of tremella polysaccharide and effects of modifiers on cellular infectivity
of NDV</article-title>. <source><italic>Int. J. Biol.
Macromol.</italic></source><volume>49</volume>: <fpage>44</fpage>&#x02013;<lpage>49</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2011.03.010</pub-id><pub-id pub-id-type="pmid">21439998</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhao</surname><given-names>X. N.</given-names></name><name><surname>Niu</surname><given-names>J. Q.</given-names></name><name><surname>Hu</surname><given-names>Y. L.</given-names></name><name><surname>Wang</surname><given-names>M. J.</given-names></name><name><surname>Huang</surname><given-names>X. Y.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Zheng</surname><given-names>T. S.</given-names></name></person-group><year>2009</year>
<article-title>Effect of tweleve Tibetan herbal medicine
on safety concentrations and growth of chicken embryo fibroblast</article-title>.
<source><italic>Chin. J. Vet. Sci.</italic></source><volume>4</volume>:
<fpage>511</fpage>&#x02013;<lpage>513</lpage>.</mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Sheng</surname><given-names>Y.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Bo</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Lou</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Bao</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><year>2012</year>. <article-title>Baicalin improves survival in a murine
model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte
apoptosis</article-title>. <source><italic>PLoS ONE</italic></source><volume>7</volume>:
<fpage>e35523</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0035523</pub-id><pub-id pub-id-type="pmid">22590504</pub-id></mixed-citation></ref></ref-list></back></article>